Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
encapsulated frozen microbiota
- Development stage
- Phase 3
- Lead developer
- Friedrich Schiller University Jena
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Encapsulated frozen microbiota is an investigational live biotherapeutic product consisting of oral capsules containing frozen fecal microbiota derived from healthy, screened multiple donors. It is being developed by the Friedrich-Schiller Universität Jena (Jena University Hospital) for the treatment of mild to moderate active ulcerative colitis. The therapy aims to restore the disrupted intestinal microbial community (gut dysbiosis) associated with the pathogenesis of inflammatory bowel disease. It is currently being evaluated in the Phase III FRESCO trial (NCT03843385), where it is compared against a sterile stool filtrate and placebo to assess its efficacy in inducing clinical remission.
- Other names
- encapsulated multidonor microbiomeFMT capsules
Beyond the preview
Go deeper on encapsulated frozen microbiota.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on encapsulated frozen microbiota.